News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Otsuka Pharmaceutical Co., Ltd. Grants Exclusive Rights To Develop And Market Rebamipide To Novartis Pharma AG (NVS)



10/19/2005 5:12:39 PM

Tokyo (JCNN) - Otsuka Pharmaceutical announced on February 7 the conclusion of a licensing agreement with Novartis AG of Switzerland on December 22.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES